Companies

Keros Therapeutics, Inc. (KROS) SEC filings

CIK 0001664710 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2021
Revenue (USD)243.9 M
Net income (USD)-104.7 M-58.7 M-45.4 M
Diluted EPS (USD/shares)2.3-5.2

Latest filings

FiledFormDescriptionPeriod
2026-09-298-K8-K items 7.01,9.012026-09-29
2026-09-288-K8-K items 7.01,9.012026-09-28
2026-09-16EFFECTEFFECT items ,,
2026-09-11DEL AMDEL AM
2026-09-10S-3S-3
2026-09-088-K8-K items 8.01,9.012026-09-08
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-19442026-08-17
2026-08-18144144
2026-08-13332026-08-04
2026-08-038-K8-K items 7.01,9.012026-08-03
2026-08-0310-Q10-Q2026-06-30
2026-08-038-K8-K items 2.02,9.012026-08-03
2026-07-308-K8-K items 7.01,9.012026-07-30
2026-07-29SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-228-K8-K items 5.022026-07-17
2026-07-17442026-07-15
2026-07-17SCHEDULE 13GSCHEDULE 13G
2026-07-06442026-07-01
2026-07-06332026-07-01
2026-06-258-K8-K items 5.02,7.01,9.012026-06-23
2026-06-17442026-06-15

Forms on file (last 1,000): 4 174, 8-K 153, 3 25, 10-Q 20, SC 13G/A 17, 144 14, DEFA14A 11, SCHEDULE 13G 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KROS (0.002 USD), /gw/filings/filings?ticker=KROS&form=8-K, /gw/filings/facts?ticker=KROS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange